Trailing-twelve-month (TTM) revenue is $3.50 Billion with a year-over-year growth of +1.65%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $860,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $977,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $823,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $838,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $3,499,600,000 |
Current P/S: $9,103,092,315 market capitalization ÷ $3,499,600,000 TTM revenue = 2.60x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:30:13.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $838.50M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:30:57.148Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $1.6B | $2.0B | $2.1B | $2.5B | $2.8B | $2.8B |
| Product And Service Other | $6M | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $629M | $729M | $408M | $461M | N/A | N/A |
| Asia Pacific Excluding China | N/A | N/A |
$3.50B
$3.50 Billion
+1.65%
vs. $3.44B a year ago (TTM)
+9.10%
5 Year compound annual growth rate
1 Year
+1.65%
3 Year
+8.83%
5 Year
+9.10%
10 Year
+8.00%
15 Year
+5.88%
20 Year
+13.00%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.44B | +$70.10M | +2.08% |
| 2024 | $3.37B | +$401.90M | +13.56% |
| 2023 | $2.96B | +$433.80M | +17.14% |
| 2022 | $2.53B | +$112.80M | +4.67% |
| 2021 | $2.42B | +$430.40M | +21.66% |
| 2020 |
TTM Growth
+1.65%
3-Year CAGR
+8.83%
5-Year CAGR
+9.10%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:30:57.148Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| Product and Service, Other | N/A | $7M | $6M | $13M | $607M | $670M |
|---|
| Service | $343M | $393M | $415M | $494M | N/A | N/A |
|---|
| N/A |
| N/A |
| $553M |
| CHINA | N/A | N/A | $397M | $528M | $471M | $476M |
|---|
| D | $245M | N/A | N/A | N/A | N/A | N/A |
|---|
| DELAWARE | N/A | $263M | N/A | N/A | N/A | N/A |
|---|
| Europe Excluding Germany | N/A | N/A | N/A | N/A | N/A | $950M |
|---|
| GERMANY | N/A | N/A | $247M | $282M | $311M | $297M |
|---|
| Other Country | $138M | $167M | $190M | $217M | $255M | $270M |
|---|
| Rest of Asia Pacific | N/A | N/A | N/A | N/A | $519M | N/A |
|---|
| Rest Of Europe | $520M | $658M | $592M | $700M | $873M | N/A |
|---|
| U | $456M | N/A | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | $601M | $696M | $778M | $939M | $891M |
|---|
| $1.99B |
| ($85.10M) |
| (4.11%) |
| 2019 | $2.07B | +$177.00M | +9.34% |
| 2018 | $1.90B | +$129.70M | +7.34% |
| 2017 | $1.77B | +$154.60M | +9.59% |
| 2016 | $1.61B | ($12.50M) | (0.77%) |
